Lisa Mahnke

Company: Nerviano Medical Sciences

Job title: President, Board Member, Chief Executive & Medical Officer

Seminars:

Roundtable Feedback Panel 3:00 pm

Following the separate roundtable discussions, this session is dedicated for the roundtable leaders to share insights, outcomes, and further questions raised on each table This will be a panel format taking audience questions to close off the day Building on earlier talks about oncogenic stress, ssDNA gaps, and clinical trial optimization, this round-up will leave…Read more

day: Pre-Conference Biomarker Focus Day PM

Exploring Next-Gen PARP Inhibitors without PARP Trapping 3:45 pm

Evaluating next-gen PARP inhibitors that selectively target PARP1 without trapping, aiming to minimize hematological toxicity and enhance safety in combination with DNA-damaging agents Focusing on improving blood-brain barrier penetration to address the unmet needs in treating brain metastases and glioblastomas Exploring the potential of these next-gen PARP inhibitors in combination with various DNA-damaging therapies to…Read more

day: Day Two